The 11th phase of HIBIO. Innovation Acceleration Camp ended with Chang Development helping innovative pharmaceutical companies to improve their R&D and drug registration levels-Business-Finance Post date May 16, 2022 — 14:36 Post Lock Read More The "Juneyao Power" who guards Shanghai with one heart: donated more than 13 million materials, and nearly 1,000 people served as volunteers… Post date May 15, 2022 — 17:16 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 9, 2022 — 00:20 Post Lock Read More Great Eastern: Acquired Pediatric Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability Post date May 8, 2022 — 19:25 Post Lock Read More 17 stocks with buy rating latest: Paine Technology CFi.CN Zhongcai Network Post date May 8, 2022 — 19:25 Post Lock Read More Great Eastern: Acquired Pediatrics Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability_Shenzhen Hotline Post date May 8, 2022 — 18:25 Post Lock Read More Overweight pediatric medical care, Juneyao Group's "century-old store" Great Eastern acquires Zhibei Medical Post date May 7, 2022 — 17:29 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The "Juneyao Power" who guards Shanghai with one heart: donated more than 13 million materials, and nearly 1,000 people served as volunteers… Post date May 15, 2022 — 17:16 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 9, 2022 — 00:20 Post Lock Read More Great Eastern: Acquired Pediatric Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability Post date May 8, 2022 — 19:25 Post Lock Read More 17 stocks with buy rating latest: Paine Technology CFi.CN Zhongcai Network Post date May 8, 2022 — 19:25 Post Lock Read More Great Eastern: Acquired Pediatrics Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability_Shenzhen Hotline Post date May 8, 2022 — 18:25 Post Lock Read More Overweight pediatric medical care, Juneyao Group's "century-old store" Great Eastern acquires Zhibei Medical Post date May 7, 2022 — 17:29 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 9, 2022 — 00:20 Post Lock Read More Great Eastern: Acquired Pediatric Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability Post date May 8, 2022 — 19:25 Post Lock Read More 17 stocks with buy rating latest: Paine Technology CFi.CN Zhongcai Network Post date May 8, 2022 — 19:25 Post Lock Read More Great Eastern: Acquired Pediatrics Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability_Shenzhen Hotline Post date May 8, 2022 — 18:25 Post Lock Read More Overweight pediatric medical care, Juneyao Group's "century-old store" Great Eastern acquires Zhibei Medical Post date May 7, 2022 — 17:29 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Great Eastern: Acquired Pediatric Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability Post date May 8, 2022 — 19:25 Post Lock Read More 17 stocks with buy rating latest: Paine Technology CFi.CN Zhongcai Network Post date May 8, 2022 — 19:25 Post Lock Read More Great Eastern: Acquired Pediatrics Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability_Shenzhen Hotline Post date May 8, 2022 — 18:25 Post Lock Read More Overweight pediatric medical care, Juneyao Group's "century-old store" Great Eastern acquires Zhibei Medical Post date May 7, 2022 — 17:29 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
17 stocks with buy rating latest: Paine Technology CFi.CN Zhongcai Network Post date May 8, 2022 — 19:25 Post Lock Read More Great Eastern: Acquired Pediatrics Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability_Shenzhen Hotline Post date May 8, 2022 — 18:25 Post Lock Read More Overweight pediatric medical care, Juneyao Group's "century-old store" Great Eastern acquires Zhibei Medical Post date May 7, 2022 — 17:29 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Great Eastern: Acquired Pediatrics Chain Institution Zhibei Medical to Improve Pediatric Diagnosis and Treatment Capability_Shenzhen Hotline Post date May 8, 2022 — 18:25 Post Lock Read More Overweight pediatric medical care, Juneyao Group's "century-old store" Great Eastern acquires Zhibei Medical Post date May 7, 2022 — 17:29 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Overweight pediatric medical care, Juneyao Group's "century-old store" Great Eastern acquires Zhibei Medical Post date May 7, 2022 — 17:29 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 02:35 Post Lock Read More Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Divestment of car sales and overweight medical field Great Eastern plans to take over 68% stake in Zhibei Medical Post date May 7, 2022 — 00:35 Post Lock Read More Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Great Eastern's latest announcement: JuneYao Medical plans to acquire 68.185% equity of Zhibei Medical for 27.75 million yuan_Stock News_Market Gold Online Post date May 6, 2022 — 21:24 Post Lock Read More Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nanbaiguo and Xihongjiu set off a battle for "the first fruit retailing" Venture Capital Channel Hexun Network Post date May 6, 2022 — 00:26 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline Post date May 6, 2022 — 00:07 Post Lock Read More Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com Post date May 5, 2022 — 21:37 Post Lock Read More Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Tianfeng Securities gave Kanglong a buy rating, with strong performance growth, and the CMC business is expected to accelerate. Post date May 5, 2022 — 17:42 Post Lock Read More Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Tianfeng Securities: Give Pharma a Buy rating_Stock News_Market Gold Online Post date May 5, 2022 — 17:40 Post Lock Read More A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A-share dividends have exceeded one trillion yuan for five consecutive years. The dividend yield of TOP50 companies has exceeded 7% Post date May 5, 2022 — 06:32 Post Lock Read More [Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[Kanglong Chemicals] Various businesses continue to develop steadily, and the 2022Q1 performance growth is in line with expectations_Financial Report Financial Times Post date April 30, 2022 — 06:30 Post Lock Read More Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Securities gives Kanglong a buy rating on Capex, with a new high and sustainable growth Post date April 29, 2022 — 12:26 Post Lock Read More Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Goldman Sachs: Maintain Pharmaron's "buy" rating, target price down to HK$167.1 Post date April 29, 2022 — 12:25 Post Lock Read More Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Securities gives Kanglong a buy rating, Capex hits a new high, and high growth is sustainable Post date April 29, 2022 — 12:23 Post Lock Read More
Caishen.CoCaishen.Co